BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25261936)

  • 61. Fluid Shear Stress Induces EMT of Circulating Tumor Cells via JNK Signaling in Favor of Their Survival during Hematogenous Dissemination.
    Xin Y; Li K; Yang M; Tan Y
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143160
    [TBL] [Abstract][Full Text] [Related]  

  • 62. LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
    Trapp EK; Majunke L; Zill B; Sommer H; Andergassen U; Koch J; Harbeck N; Mahner S; Friedl TWP; Janni W; Rack B; Alunni-Fabbroni M
    Mol Oncol; 2017 Nov; 11(11):1508-1526. PubMed ID: 28700115
    [TBL] [Abstract][Full Text] [Related]  

  • 63. EMT-independent detection of circulating tumor cells in human blood samples and pre-clinical mouse models of metastasis.
    Kitz J; Goodale D; Postenka C; Lowes LE; Allan AL
    Clin Exp Metastasis; 2021 Feb; 38(1):97-108. PubMed ID: 33415568
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
    Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
    Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease-free survival in low-risk breast cancer patients.
    Zmetakova I; Kalinkova L; Smolkova B; Horvathova Kajabova V; Cierna Z; Danihel L; Bohac M; Sedlackova T; Minarik G; Karaba M; Benca J; Cihova M; Buocikova V; Miklikova S; Mego M; Fridrichova I
    Cancer Sci; 2019 May; 110(5):1695-1704. PubMed ID: 30815959
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma.
    Bao W; Qiu H; Yang T; Luo X; Zhang H; Wan X
    PLoS One; 2013; 8(7):e70616. PubMed ID: 23936232
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
    Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer.
    Papadaki MA; Stoupis G; Theodoropoulos PA; Mavroudis D; Georgoulias V; Agelaki S
    Mol Cancer Ther; 2019 Feb; 18(2):437-447. PubMed ID: 30401696
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis.
    Roth B; Jayaratna I; Sundi D; Cheng T; Melquist J; Choi W; Porten S; Nitti G; Navai N; Wszolek M; Guo C; Czerniak B; McConkey D; Dinney C
    Oncotarget; 2017 May; 8(21):34205-34222. PubMed ID: 27494900
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients.
    Markou A; Lazaridou M; Paraskevopoulos P; Chen S; Świerczewska M; Budna J; Kuske A; Gorges TM; Joosse SA; Kroneis T; Zabel M; Sedlmayr P; Alix-Panabières C; Pantel K; Lianidou ES
    Clin Chem; 2018 Feb; 64(2):297-306. PubMed ID: 29122836
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
    Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
    BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
    [TBL] [Abstract][Full Text] [Related]  

  • 72. mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.
    Mostert B; Sieuwerts AM; Bolt-de Vries J; Kraan J; Lalmahomed Z; van Galen A; van der Spoel P; de Weerd V; Ramírez-Moreno R; Smid M; Verhoef C; IJzermans JN; Gratama JW; Sleijfer S; Foekens JA; Martens JW
    Mol Oncol; 2015 Apr; 9(4):920-32. PubMed ID: 25655581
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients.
    Papadaki MA; Aggouraki D; Vetsika EK; Xenidis N; Kallergi G; Kotsakis A; Georgoulias V
    Anticancer Res; 2021 Feb; 41(2):661-670. PubMed ID: 33517270
    [TBL] [Abstract][Full Text] [Related]  

  • 74. HOTAIR in relation to epithelial-mesenchymal transition and cancer stem cells in molecular subtypes of endometrial cancer.
    Łuczak A; Supernat A; Łapińska-Szumczyk S; Jachimowicz D; Majewska H; Gulczyński J; Żaczek AJ
    Int J Biol Markers; 2016 Jul; 31(3):e245-51. PubMed ID: 26868332
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A microchip filter device incorporating slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads.
    Kim YJ; Koo GB; Lee JY; Moon HS; Kim DG; Lee DG; Lee JY; Oh JH; Park JM; Kim MS; Woo HG; Kim SI; Kang P; Choi W; Sim TS; Park WY; Lee JG; Kim YS
    Biomaterials; 2014 Aug; 35(26):7501-10. PubMed ID: 24917030
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck.
    Balasubramanian P; Lang JC; Jatana KR; Miller B; Ozer E; Old M; Schuller DE; Agrawal A; Teknos TN; Summers TA; Lustberg MB; Zborowski M; Chalmers JJ
    PLoS One; 2012; 7(7):e42048. PubMed ID: 22844540
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer.
    Wu F; Zhu J; Mao Y; Li X; Hu B; Zhang D
    Dis Markers; 2017; 2017():9474532. PubMed ID: 29430076
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
    Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
    Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
    Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
    Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
    Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.